SELLAS Life Sciences Group's total assets for Q1 2025 were $34.96M, an increase of 79.89% from the previous quarter. SLS total liabilities were $7.20M for the fiscal quarter, a -27.79% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.